Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  American Journal of Surgery

• Publication date

  1986-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9610(86)90038-3PMID 2872829
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gastrinoma: factors influencing prognosis.

  1985cited by this paper
• Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.

  1985cited by this paper
• Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.

  1985cited by this paper
• Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.

  1985cited by this paper
• Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones.

  1985cited by this paper
• Effect of intravenous somatostatin on stool output in diarrhea due to Vibrio cholerae.

  1984cited by this paper
• Thirty years' experience with gastrinoma

  1984cited by this paper
• Can inhibition of hormone secretion be associated with endocrine tumour shrinkage?

  1983cited by this paper
• SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.

  1982cited by this paper
• The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man.

  1981cited by this paper
• The distribution and characterization of somatostatin-like immunoreactivity in epithelial cells, submucosa, and muscle of the rat stomach and intestine.

  1981cited by this paper
• Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes

  1980cited by this paper
• Primary Peptic Ulcerations of the Jejunum Associated with Islet Cell Tumors: Twenty‐five‐year Appraisal

  1980cited by this paper
• Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes.

  1980cited by this paper
• Somatostatinoma syndrome. Biochemical, morphologic and clinical features.

  1979cited by this paper
• Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man.

  1979cited by this paper
• Effects of pancreatic polypeptide and vasoactive intestinal polypeptide on rat ileal and colonic water and electrolyte transportin vivo

  1979cited by this paper
• Highly active position eight analogues of somatostatin and separation of peptide diastereomers by partition chromatography.

  1978cited by this paper
• Gastrointestinal somatostatin: extraction and radioimmunoassay in different species.

  1978cited by this paper
• "Somatostatinoma": a somatostatin-containing tumor of the endocrine pancreas.

  1977cited by this paper
• Observations on the Postoperative Tumor Growth Behavior of Certain Islet Cell Tumors

  1976cited by this paper
• Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells.

  1975cited by this paper
• Somatostatin: abundance of immunoreactive hormone in rat stomach and pancreas.

  1975cited by this paper
• Effects of somatostatin on gastric secretion and gastrin release in man.

  1975cited by this paper
• Editorial: Somatostatin: newcomer from the hypothalamus.

  1974cited by this paper
• Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone.

  1974cited by this paper
• Letter: Complement components in cystic fibrosis.

  1973cited by this paper
• Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

  1973cited by this paper
• Primary Peptic Ulcerations of the Jejunum Associated with Islet Cell Tumors of the Pancreas

  1955cited by this paper

• Evaluation of somatostatin analogues for the detection and treatment of gastrinoma in a dog.

  1997cites this paper
• Diagnosis and treatment of gastrinoma.

  1997cites this paper
• Islet cell tumors of the pancreas.

  1995cites this paper
• Gastrointestinal neuroendocrine tumors.

  1994cites this paper
• Management of unresectable malignant endocrine tumors of the pancreas.

  1993cites this paper
• Therapeutic strategies in the management of endocrine GEP tumours

  1990cites this paper
• Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome.

  1990cites this paper
• Functional endocrine tumors of the pancreas: clinical presentation, diagnosis, and treatment.

  1990cites this paper
• Adult onset nesidioblastosis: response of glucose, insulin, and secondary peptides to therapy with Sandostatin.

  1990cites this paper
• Immunocytochemical localization and identification of prosomatostatin gene products in medullary carcinoma of human thyroid gland.

  1990cites this paper
• Octreotide

  1989cites this paper
• Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases.

  1989cites this paper
• Aggressive Insulinoma with Bone Metastases

  1989cites this paper
• Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors

  1989cites this paper
• The use of the long-acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors.

  1989cites this paper
• Somatostatin and Somatostatin Analogue (SMS 201-995) in Treatment of Hormone-Secreting Tumors of the Pituitary and Gastrointestinal Tract and Non-Neoplastic Diseases of the Gut

  1989cites this paper
• Medical therapy of VIPomas.

  1989cites this paper
• Hormonal manipulation of gastrointestinal cancer by gut peptides

  1988cites this paper
• Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors.

  1988cites this paper
• Oncological applications of somatostatin analogues.

  1988cites this paper
• Role of gastrin and cholecystokinin in tumours of the gastrointestinal tract.

  1988cites this paper
• Long‐Acting Somatostatin (SMS 201‐995) in the Management of Zollinger‐Ellison Syndrome: Evidence for Sustained Efficacy

  1988cites this paper
• The use of SMS 201-995 (somatostatin analogue) in insulinomas. Additional case report and literature review.

  1988cites this paper
• Advances in drug therapy for peptic ulcer disease.

  1987cites this paper
• Clinical and pathophysiological aspects of somatostatin and the gastrointestinal tract.

  1987cites this paper